GOODWILL AND INTANGIBLE ASSETS:

12 Months Ended

Dec. 31, 2013

NOTE 6— GOODWILL AND INTANGIBLE ASSETS:

The following table represents changes in the carrying amount of goodwill (in thousands):

Balance as of December 31, 2012	$	132,885
Goodwill from IPtronics acquisition	25,630
Goodwill from Kotura acquisition	40,681
Adjustments	—
Balance as of December 31, 2013	$	199,196

The carrying amounts of intangible assets as of December 31, 2013 were as follows:

	Gross Carrying Value		Accumulated Amortization			Net Carrying Value
	(in thousands)

Licensed technology	$	2,344	$	(366	)	$	1,978
Developed technology	56,064		(24,654		)	31,410
Customer relationships	13,376		(6,279		)	7,097
Customer contract	1,529		(1,529		)	—
Backlog	726		(726		)	—
Total amortizable intangible assets	$	74,039	$	(33,554	)	$	40,485
IPR&D	13,764		—			13,764
Total intangible assets	$	87,803	$	(33,554	)	$	54,249

The carrying amounts of intangible assets as of December 31, 2012 were as follows:

	Gross Carrying Value		Accumulated Amortization			Net Carrying Value
	(in thousands)
Licensed technology	$	946	$	(946	)	$	—
Developed technology	23,132		(14,695		)	8,437
Customer relationships	10,956		(3,328		)	7,628
Customer contract	1,529		(1,460		)	69
Total intangible assets	$	36,563	$	(20,429	)	$	16,134

Amortization expense of intangible assets totaled approximately $14.0 million, $9.3 million and $9.4 million for the years ended December 31, 2013, 2012 and 2011, respectively.

The estimated future amortization expense from amortizable intangible assets is as follows (in thousands):

2014	$	12,869
2015	10,761
2016	9,945
2017	9,882
2018 and thereafter	10,792
	$	54,249

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References+ Details